Quality Control and Evaluation in Standard COPD Management
- Conditions
- COPD
- Interventions
- Other: GOLD 2017
- Registration Number
- NCT03314077
- Lead Sponsor
- Tongji Hospital
- Brief Summary
There is lack of quality control and evaluation indexes for standard COPD management in hospitals in China, leading to nonstandard in COPD management and discrepancy in therapeutic efficiency. This study focuses on establishing quality control and evaluation indexes for standard COPD management in hospitals in China, and evaluating the therapeutic efficiency after standard COPD management. This part is a prospective cohort which lasts 2 years. After standard COPD management according to GOLD 2017 by doctors in hospitals in China, patients will be followed up for their outcome after 1 year. Several indexes will be selected to evaluate the quality control of standard COPD management and its efficiency. The controls are from hospital-based subjects with a retrospective cohort study.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 210
- 1.Clinical manifestation of COPD; post bronchodilator FEV1/FVC<0.70
-
- lung cancer. 2. Any history of psychiatric disorders. 3.HIV positive. 4.Breastfeeding, pregnancy or planning to be pregnant. 5.Estimated lifetime less than 1 years due to underlying diseases.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Standard managed subjects GOLD 2017 COPD patients accepted standard COPD management.
- Primary Outcome Measures
Name Time Method Change in spirometry 1 years Spirometry will be assessed at baseline and through study completion
- Secondary Outcome Measures
Name Time Method Morbidity of acute exacerbation in 1 years 1 year Morbidity of acute exacerbation completion will be assessed at baseline and through study
Trial Locations
- Locations (2)
Tongji hospital
🇨🇳Wuhan, Hubei, China
TongjiChibi hospital
🇨🇳Chibi, Hubei, China